Report cover image

Allergy Diagnostics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

Publisher Global Market Insights
Published Mar 05, 2025
Length 127 Pages
SKU # GMI19969793

Description

The Global Allergy Diagnostics Market was valued at USD 5.6 billion in 2024 and is poised to grow at a CAGR of 9.2% between 2025 and 2034. Allergy diagnostics focuses on a range of tests, services, and technologies designed to identify specific allergens responsible for allergic reactions in patients. These solutions are vital for the detection of various allergic disorders, including food allergies, respiratory allergies, and drug allergies. The increasing prevalence of allergic conditions worldwide, driven by environmental changes, pollution, and lifestyle shifts, is significantly fueling market expansion. Furthermore, rising awareness about allergy diagnostics, technological advancements in testing solutions, and increasing healthcare expenditure are fostering market growth.

Based on product and service, the allergy diagnostics market is segmented into instruments, consumables, and services. The services segment accounted for a significant USD 2.8 billion in 2024 and is expected to witness robust growth through 2034. The demand for allergy diagnostic services is propelled by the rising number of patients seeking clinical evaluations for various allergic reactions. Services such as test administration, laboratory analysis, and result interpretation are increasingly sought after to manage the growing burden of allergies. Further, partnerships between hospitals and specialized diagnostic laboratories are supporting the growth of this segment as healthcare providers seek to offer comprehensive allergy testing services to improve patient outcomes.

By test type, the in vivo segment of the allergy diagnostics market includes skin prick tests (SPT), intradermal tests, and patch tests. The segment is projected to reach USD 8.2 billion by 2034, owing to the widespread use of skin prick tests, which remain a gold standard for allergy detection due to their high sensitivity, rapid results, and cost-effectiveness. In vivo tests provide real-time assessment of allergic reactions, offering immediate insights for clinicians to determine treatment pathways. The continued development of minimally invasive and patient-friendly testing methodologies is expected to bolster segment growth further.

By allergen, the market is segmented into food allergens, inhaled allergens, drug allergens, and others. Among these, the inhaled allergens segment is forecasted to reach USD 7 billion by 2034. The surge in respiratory allergic conditions, including asthma, allergic rhinitis, and sinusitis, is a key driver. Pollen, dust mites, mold spores, and pet dander are among the primary inhaled allergens tested through diagnostic solutions. Increasing exposure to environmental pollutants and urbanization has escalated the demand for inhaled allergen diagnostics, especially in developed and urban settings.

Based on end-use, the allergy diagnostics market is segmented into hospital-based laboratories, diagnostic laboratories, academic research institutes, and others. The hospital-based laboratories segment dominated the market in 2024 and is projected to exceed USD 7.1 billion by 2034. The growth of this segment is attributed to increasing hospital admissions related to severe allergic reactions, such as anaphylaxis and asthma exacerbations. Hospital laboratories are well-equipped to conduct various allergy diagnostics, including in vivo and in vitro tests, often integrating them into routine diagnostic workflows. Moreover, hospital-based labs facilitate quick turnaround times for allergy testing, supporting timely intervention and treatment for patients, thus enhancing their adoption and market penetration.

Geographically, North America led the global allergy diagnostics market in 2024 and is anticipated to surpass USD 5.2 billion by 2034, fueled by rising allergic disease prevalence, advanced healthcare infrastructure, and growing adoption of sophisticated diagnostic technologies. The U.S. and Canada are at the forefront due to high awareness, significant investments in healthcare, and increasing collaborations between diagnostic companies and healthcare providers. Additionally, favorable reimbursement policies and continuous advancements in diagnostic technologies, such as molecular diagnostics and CRD, are further strengthening regional market growth.

Table of Contents

127 Pages
Chapter 1 Methodology
1.1 Market segmentation
1.2 Market definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Revenue share analysis (Global Market analysis)
1.4.2 Approach 2: Investor presentations
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global market 360° synopsis, 2021- 2034 (USD Billion)
2.2 Business trends
2.3 Product and service trends
2.4 Test type trends
2.5 Allergen trends
2.6 End use trends
2.7 Regional trends
Chapter 3 Allergy Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence and high economic burden of allergic diseases
3.2.1.2 Growing pollution levels coupled with rise in respiratory disorders
3.2.1.3 Rise in funding for allergy diagnostics companies
3.2.1.4 Pediatric allergy awareness
3.2.1.5 Technological advancements in new products
3.2.2 Restraints
3.2.2.1 High cost of allergy diagnostic instrument
3.3 Growth potential analysis
3.3.1 By product and service
3.3.2 By test type
3.3.3 By allergen
3.3.4 By end use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technological landscape
3.6 Gap analysis
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Value chain analysis
3.11 Innovations in allergy diagnostics and management
3.12 The future of food allergy diagnosis
3.13 AI-enhanced allergy diagnostics
Chapter 4 Competitive Landscape
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Allergy Diagnostics Market, By Product and Service
5.1 Services
5.2 Consumables
5.3 Instruments
Chapter 6 Allergy Diagnostics Market, By Test Type
6.1 In vivo
6.1.1 Skin prick tests
6.1.2 Intradermal skin test
6.1.3 Other in vivo test type
6.2 In vitro
6.2.1 IgE-based allergy tests
6.2.2 IgG-based allergy tests
6.2.3 Other in vitro test type
Chapter 7 Allergy Diagnostics Market, By Allergen
7.1 Inhaled allergens
7.2 Food allergens
7.3 Drug allergens
7.4 Other allergens
Chapter 8 Allergy Diagnostics Market, By End Use
8.1 Hospitals-based laboratories
8.2 Diagnostic laboratories
8.3 Other end users
Chapter 9 Allergy Diagnostics Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profile
10.1 AgnitioST
10.1.1 Global overview
10.1.2 Business overview
10.1.3 Financial data
10.1.4 Product landscape
10.1.5 SWOT analysis
10.2 bioMérieux, Inc.
10.2.1 Global overview
10.2.2 Business overview
10.2.3 Financial data
10.2.3.1 Annual sales revenue, 2020-2023 (USD Million)
10.2.4 Product landscape
10.2.5 SWOT analysis
10.3 Danaher Corporation (Beckman Coulter)
10.3.1 Global overview
10.3.2 Business overview
10.3.3 Financial data
10.3.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.3.4 Product landscape
10.3.5 Strategic outlook
10.3.6 SWOT analysis
10.4 Eurofins Scientific SE
10.4.1 Global overview
10.4.2 Business overview
10.4.3 Financial data
10.4.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.4.4 Product landscape
10.4.5 Strategic outlook
10.4.6 SWOT analysis
10.5 EUROIMMUN
10.5.1 Global overview
10.5.2 Business overview
10.5.3 Financial data
10.5.3.1 Annual sales revenue, 2021-2024 (USD Million)
10.5.4 Product landscape
10.5.5 Strategic outlook
10.5.6 SWOT analysis
10.6 Excelsior Bio-System, Inc.
10.6.1 Global overview
10.6.2 Business overview
10.6.3 Financial data
10.6.4 Product landscape
10.6.5 SWOT analysis
10.7 HollisterStier Allergy
10.7.1 Global overview
10.7.2 Business overview
10.7.3 Financial data
10.7.4 Product landscape
10.7.5 SWOT analysis
10.8 HYCOR Biomedical
10.8.1 Global overview
10.8.2 Business overview
10.8.3 Financial data
10.8.4 Product landscape
10.8.5 Strategic outlook
10.8.6 SWOT analysis
10.9 LINCOLN Diagnostics Inc.
10.9.1 Global overview
10.9.2 Business overview
10.9.3 Financial data
10.9.4 Product landscape
10.9.5 Strategic outlook
10.9.6 SWOT analysis
10.10 Med Phar Enterprise Co.
10.10.1 Global overview
10.10.2 Business overview
10.10.3 Financial data
10.10.4 Product landscape
10.10.5 SWOT analysis
10.11 Neogen Corporation
10.11.1 Global overview
10.11.2 Business overview
10.11.3 Financial data
10.11.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.11.4 Product landscape
10.11.5 Strategic outlook
10.11.6 SWOT analysis
10.12 Omega Diagnostics Ltd
10.12.1 Global overview
10.12.2 Business overview
10.12.3 Financial data
10.12.3.1 Annual sales revenue, 2021-2024 (USD Million)
10.12.4 Product landscape
10.12.5 SWOT analysis
10.13 REGA BIOTECHNOLOGY INC
10.13.1 Global overview
10.13.2 Business overview
10.13.3 Financial data
10.13.4 Product landscape
10.13.5 Strategic outlook
10.13.6 SWOT analysis
10.14 SGS TAIWAN
10.14.1 Global overview
10.14.2 Business overview
10.14.3 Financial data
10.14.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.14.4 Product landscape
10.14.5 Strategic outlook
10.14.6 SWOT analysis
10.15 Siemens Healthineers AG
10.15.1 Global overview
10.15.2 Business overview
10.15.3 Financial data
10.15.3.1 Annual sales revenue, 2020 - 2023 (USD Million)
10.15.4 Product landscape
10.15.5 SWOT analysis
10.16 Stallergenes Greer
10.16.1 Global overview
10.16.2 Business overview
10.16.3 Financial data
10.16.4 Product landscape
10.16.5 SWOT analysis
10.17 Thermo Fisher Scientific, Inc.
10.17.1 Global overview
10.17.2 Business overview
10.17.3 Financial data
10.17.3.1 Annual sales revenue, 2021 - 2024 (USD Million)
10.17.4 Product landscape
10.17.5 Strategic outlook
10.17.6 SWOT analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us